Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma

Authors

C Paustian
Matthew Taylor, ProvidenceFollow
Will Redmond, ProvidenceFollow
B Bernard, Providence
RB Bell, ProvidenceFollow
Carlo Bifulco, ProvidenceFollow
Brian Piening, ProvidenceFollow
Walter Urba, ProvidenceFollow
Bernard Fox, ProvidenceFollow
Rom Leidner, ProvidenceFollow
See full list of authors in comments

Document Type

Abstract

Publication Date

11-1-2023

Keywords

oregon; chiles

Clinical Institute

Cancer

Department

Oncology

Comments

Paustian C, Moudgil T, Rajamanickam V, Simons N, Meng R, Couey M, Taylor MH, Koguchi Y, Stadum A, Christie T, Hulett T, Iwamoto N, Shimada T, Minegishi Y, Vu Q, Redmond WL, Rushforth L, Peterson A, Bernard B, Bell RB, Bifulco C, Ueda K, Hilton T, Jensen SM, Hu H-M, Piening B, Urba WJ, Fox BA, Leidner RS. SITC Annual Meeting; November 1-5; San Diego, CA. 2023;11(Suppl 1): 680

Recommended Citation

Paustian, C; Taylor, Matthew; Redmond, Will; Bernard, B; Bell, RB; Bifulco, Carlo; Piening, Brian; Urba, Walter; Fox, Bernard; Leidner, Rom; and See full list of authors in comments, "Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma" (2023). Articles, Abstracts, and Reports. 8357.
https://digitalcommons.providence.org/publications/8357